Oxford Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Oxford Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-44,238	Closed	-$208K	–	1547
2019 Q4	$208K	Buy	+44,238	New	+$181K	0.01%	1546
2017 Q1	–	Sell	-157,376	Closed	-$367K	–	1513
2016 Q4	$367K	Buy	+157,376	New	+$300K	0.01%	635
2016 Q3	–	Sell	-47,032	Closed	-$49K	–	892
2016 Q2	$49K	Buy	+47,032	New	+$45.4K	﹤0.01%	756
2015 Q3	–	Sell	-267,639	Closed	-$557K	–	747
2015 Q2	$557K	Buy	+267,639	New	+$649K	0.02%	515
2014 Q2	–	Sell	-65,746	Closed	-$230K	–	806
2014 Q1	$230K	Buy	+65,746	New	+$292K	0.01%	583

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Oxford Asset Management's ATRS Position: Q1 2020 in Review

Oxford Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q1 2020, closing a stake of 44,238 shares — an estimated $208K sold.

Oxford Asset Management first reported a position in ATRS in Q1 2014 and held it in 5 quarters. The position peaked at $557K in Q2 2015. 154 funds tracked by Wall St. Rank hold ATRS as of Q1 2020.

Oxford Asset Management reported no remaining Antares Pharma, Inc. position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 44,238 Antares Pharma, Inc. shares in Q1 2020, an estimated $208K.
Oxford Asset Management first reported a position in Antares Pharma, Inc. in Q1 2014 and held it in 5 quarters.
Oxford Asset Management's Antares Pharma, Inc. position peaked at $557K in Q2 2015.
154 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.